Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rome Therapeutics

Request full access

Developing novel therapies for cancer and autoimmune diseases treatment by harnessing the power of the repeatome

Cambridge, United StatesFounded 2020Biotech & Life Sciences

About Rome Therapeutics

RomeTX is a startup operating in the digital space, providing an innovative and interactive online platform. The company's website, rometx.com, is designed with a user-friendly interface that engages visitors with a dynamic splash screen. The website's functionality includes a toggle feature that allows users to switch the display on and off, providing a unique user experience.

The company primarily serves clients who are looking for a modern and interactive digital experience, which includes businesses across various sectors that want to enhance their online presence. RomeTX operates in the competitive digital market, where the demand for unique and engaging online experiences is high.

RomeTX's business model is centered around providing digital solutions. While the exact monetization strategy is not explicitly stated, it can be inferred that the company generates revenue through providing digital services, which could include website design and development, digital marketing, and other related services.

In conclusion, RomeTX is a dynamic startup offering unique digital experiences. It operates in a competitive market, serving clients across various sectors and generating revenue through the provision of digital services.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
16
Open positions
None listed
Dealroom signal
61.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2026 $0 — Pretzel ↗
SERIES BOther financing Sep 2023 $72M $385M Andreessen Horowitz · GV · Casdin Capital · Mirae Asset Capital ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Rome Therapeutics website traffic

Latest recorded traffic for Rome Therapeutics is 1.7K monthly website visits, down 48.5% over the last three months. Rome Therapeutics's team declined 38.5% over the past year.

Latest monthly visits1.7K 3-month web change-48.5% 1-year team growth-38.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Rome Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Rome Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A16 investors entered at this stage

Other known investors2 additional known investors

  • Massachusetts Institute of Technology
  • Pretzel
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rome Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rome Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.